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Key Messages
1. For management of simple 
lacerated wounds, tissue 
adhesive (Dermabond) 
achieved more positive 
outcomes but incurred higher 
cost, compared with standard 
sutures. 
2. Dermabond may be more cost-
effective than standard sutures 
from a societal viewpoint. 
3. Use of sutures required more 
nursing time and additional 
costs from subsequent dressing, 
whereas use of Dermabond 
incurred higher equipment 
costs.
4. Dermabond achieved better 
appearance outcome and 
patient satisfaction, compared 
with sutures. 
5. Pain levels were not significantly 
different in patients treated 
with Dermabond or sutures.
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Introduction
In Hong Kong, nearly 3500 wound closures are handled by each accident and 
emergency department (AED) each year.1 Suturing is a painful procedure and 
requires competent skill and follow-up visits for suture removal.2,3 Dermabond 
(2-octyl cyanoacrylate) is a tissue adhesive used as a wound closure alternative.2-5 
Dermabond and sutures achieve equivalent healed wound appearance, but 
Dermabond entails a shorter procedure time and results in greater patient 
satisfaction than sutures.2,3 We aimed to compare Dermabond versus standard 
wound sutures in terms of cost-effectiveness, outcome appearance, infection 
rate, pain, and satisfaction.
Methods 
This randomised, unblinded, controlled study was conducted from 1 October 
2005 to 30 September 2006. Patients from AEDs of two regional hospitals of 
Hong Kong who were aged ≥18 years, ambulatory, and had simple laceration 
wound of <8 cm were invited to participate. Patients with complicated wounds, 
scalp wounds, physical, visual or cognitive impairment were excluded. Patients 
were randomly assigned to either the control group (wound closure by sutures 
using standard nylon stitches) or experimental group (wound closure by tissue 
adhesive—Dermabond). Wound closure was defined as the process of realigning 
lacerated tissue plane. An intention-to-treat method was used for analysis. 
 Wounds were disinfected. For the suture group, the wound was anaesthetised 
with lignocaine 1% and sutured using standard nylon stitiches by AED nurses. 
After wound closure, simple dressings (plain gauze or band aid) was applied to 
cover the wound until removal. On discharge, a wound care instruction sheet 
was provided, and an out-patient follow-up was arranged for suture removal (or 
dressing as necessary). 
 For the Dermabond group, no local anaesthetic agent was used. Dermabond 
was gently ‘painted’ on the wound sites by AED nurses, and the wound edges 
were held together for at least 30 seconds to ensure adequate polymerisation. On 
discharge, a wound care instruction sheet was provided. No wound follow-up 
was arranged. Clinical data of the patients was recorded by the research assistant 
at three time points: day 14, month 1, and month 3. 
 
 A wound evaluation score (WES) was used to assess six clinical variables: 
absence of step off, contour irregularities, wound margin separation, edge 
inversion, excessive distortion, and overall cosmetic appearance. The total WES 
was derived by the addition of the ‘yes’ responses to the six variables; a score of 
six indicates optimal and <6 as sub-optimal wound appearance.4 
 A visual analogue cosmesis scale (VACS) was used to assess each patient’s 
degree of satisfaction with wound appearance outcome after suture removal, 
with 0 indicating least satisfied and 100 most satisfied. A visual analogue scale 
(VAS) was used to assess the level of pain during the wound closure process, 
with 0 indicating least pain and 100 most pain. 
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 A wound infection tool was used to derive a wound 
score, which was calculated by a reviewer for wound 
separation, and exudates or erythema from the line of the 
incision. A score of 0 indicated normal healing and 30 
complete dehiscence of the wound. 
 The patient satisfaction for the overall wound 
management process was also assessed using a scale of 
0 (least satisfied) to 100 (most satisfied). In addition, 
analgesic consumption at home, rate of wound follow-up, 
and adverse reactions after wound closure were recorded.
 The total costs of both treatments were compared. All 
activities related to the treatment or subsequent unexpected 
outcomes for each patient were recorded. A full cost (total 
doctor and nursing time of the whole procedure, actual cost 
of materials, analgesic consumption) for each patient was 
calculated. The costs for the suture and Dermabond groups 
were compared for cost-effectiveness analysis. Based on a 
hospital perspective, incremental cost-effective ratio was used. 
Results
Of 201 patients, 105 were treated with Dermabond and 96 
with sutures (Fig 1). There was no significant difference 
between groups in terms of age, gender, co-existing 
illness, and baseline variables of pain level, mechanism of 
injury, injury site, wound length, and time from injury to 
presentation (Table 1). 
 At day 14, more percentage of patients in the Dermabond 
group achieved the optimal WES (89.5% vs 86.5%, P=0.29, 
Table 2). The difference was significant when using VACS 
perceived by the reviewer (79.1 vs 66.5, P<0.005, t test). 
 At month 3, using VACS as the dependent variable with 
potential confounders (such as sex, age, wound length, 
wound life, and baseline appearance score), multiple 
regression analysis showed that only wound length had 
a significant effect on VACS (effect= –2.88, standard 
error=0.91, P=0.002). Repeated measure ANOVA was used 
to test the group difference in terms of VACS perceived 
by the participants at the four time points. There was a 
significant main effect for intervention (f (1,198)=8.6, 
P=0.004); the Dermabond group had significantly higher 
mean score than the suture group (83.3 vs 75 at day 14, 89.3 
vs 81 at month 1, and 92.5 vs 85.4 at month 3 (P<0.001, 
Table 2, Fig 2). 
Table 1. Baseline characteristics
Variable All patients (n=201) Dermabond group (n=105) Suture group (n=96)
No. (%) of patients from hospital A 112 (56) 58 (55) 54 (56)
No. (%) of patients from hospital B 89 (44) 47 (45) 42 (44)
Mean±SD patient age (years) 42.7±19.1 43±19.4 42.5±18.9
No. (%) of males 138 (68.7) 71 (67.6) 67 (69.8)
No. (%) of patients with diabetes mellitus 8 (4.0) 4 (3.8) 4 (4.2)
Median (IQR) time from injury to presentation (minutes) 44 (30-61) 43 (30-58) 45 (32.5-64)
Mechanisms of injury (No. [%] of patients)
Contusion 32 (15.9) 19 (18.1) 13 (13.5)
Cut 115 (57.2) 63 (60) 52 (54.2)
Falls 43 (21.4) 17 (16.2) 26 (27.1)
Motor vehicle accident 2 (1.0) 2 (1.9) 0 (0)
Sports 9 (4.5) 4 (3.8) 5 (5.2)
Site of injury (No. [%] of patients)
Face 89 (44.3) 51 (48.6) 38 (39.6)
Hand 85 (42.3) 42 (40) 43 (44.8)
Lower limb 12 (6.0) 5 (4.8) 7 (7.3)
Upper limb 13 (6.5) 6 (5.7) 7 (7.3)
Chest 2 (1.0) 1 (1.0) 1 (1.0)
Median (25th-75th quartiles) wound length (cm) 1.7 (1-2) 1.5 (1-2) 2.0 (1-2)
Fig 1. Flow chart of patient randomisation
Eligible patients (n=341)
Patients randomised to treatment (n=201)
Suture group (n=96)
Follow-up on day 14 
(n=94)
Follow-up on day 14 
(n=103)
Phone follow-up on 
month 1 (n=103)
Phone follow-up on 
month 3 (n=105)
Analysed (n=105) Analysed (n=96)
Phone follow-up on 
month 3 (n=95)
Phone follow-up on 
month 1 (n=93)
140 patients excluded:
Refused participation (n=37)
Scalp wound (n=43)
Lip involvement (n=10)
Deep laceration with muscle 
involvement (n=13)
Fracture/nerve involvement (n=20)
Wound length of >8cm (n=12)
Heavily contaminated wound (n=5)
Dermabond group 
(n=105)
104 completed the 
procedure; four converted 
to suture because of 
re-bleeding during wound 
preparation
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 A difference of 15 in the VACS score was defined as the 
minimum clinically important between optimal and sub-
optimal scar.14,24 The mean VACS scores at baseline were 
similar between groups, and the absolute differences at day 
14 and months 1 and 3 were not clinically significant (<10), 
despite the Dermabond group having higher scores (Table 2). 
 The mean VAS scores for pain at baseline were similar 
between groups (Fig 3). Repeated measure ANOVA of 
VAS scores for pain as perceived by participants at the 
four time points showed no significant main effect for 
intervention (f (1,198)=2.67, P=0.10, Table 2 and Fig 2). 
The absolute differences at day 14, months 1 and 3 were all 
<5 (a minimum difference of 13 was regarded as clinically 
significant).
 Infection score (0-30 scale) at day 14 was significantly 
lower in the Dermabond group (0.09 vs 0.61, P=0.011, t 
test). As the infection rate was low in both groups, sub-scale 
analysis revealed that there was a higher rate of erythema/
swelling in the suture group (Table 2). The overall patient 
satisfaction score was higher in the Dermabond group (91.6 
vs 85.3, P<0.0005).
 The mean time to wound closure was longer in the 
suture group (9 vs 15, P<0.005), and therefore the mean 
total nurse time used was also longer (20.8 vs 28.1 minutes, 
P<0.005). The use of Dermabond could reduce the wound 
closure time and the nurse time. 
 Respectively in the Dermabond and suture group, 
the overall mean costs were HK$241.69 and HK$204.02 
(Table 3), and the improvements in mean VACS scores 
were 30.7 and 23.3. To improve the score on wound 
appearance by one using Dermabond rather than sutures, 
an additional HK$5.1 (HK$241.69-204.02/30.7-23.3) 
was incurred. 
 Dermabond costs about HK$140 per vial, whereas 
sutures cost HK$9.5 per package. The higher cost in 
Dermabond use was mainly due to the equipment cost. 
Sutures entailed suture removal and more frequent follow-
ups for dressing. The substantial cost difference stemmed 
mainly from the follow-up visits and need to remove 
stitches (HK$68.5 vs HK$8.2). The suture group drained 
more nurse services, whereas the Dermabond group 
incurred a higher equipment cost. Nevertheless, there was 
no significant difference in costs related to doctors. 
Discussion
Cost-effectiveness: hospital administration 
consideration 
The high material cost of the Dermabond could not be 
offset by its low cost in subsequent wound care. Given the 
similar clinical outcomes, the conventional suture method 
appeared to be the preferred method for wound closure 
from the perspective of hospitals, despite lower infection 
rate, better wound appearance and patient satisfaction for 
Table 2. Outcome measures between two groups at different time points
Variable Dermabond group Suture group Absolute difference 
(95% CI)
P value
Visual analogue cosmesis scale score (mean [95% CI])
Baseline (after wound closure) 60.8 (60.2-61.5) 62.3 (61.3-63.3) 1.5 (0.4-3.5) -
Day 14 83.3 (79.6-87.0) 75.0 (71.3-78.5) 8.3 (3.7-13.7) -
Day 14 (assessed by research assistant) 79.1 (75.5-84.4) 66.5 (60.6-70.2) 15.5 (8.3-22.2) <0.001*
Month 1 89.3 (86.1-92.6) 80.9 (77.6-84.3) 8.4 (4.0-12.7) -
Month 3 92.5 (89.9-95.1) 85.4 (82.8-88.1) 7.1 (3.4-10.8) -
Mean difference (baseline vs month 3) [mean±SD] 30.7±14 23.3±14 - <0.001* 
Appearance complication at day 14 using wound evaluation 
score (WES) [No. (%) of patients]
Step off 3 (2.9) 1 (1.1) - 0.34†
Contour irregularities 1 (0.95) 2 (2.1) - 0.47†
Wound margin separation of >2 mm 2 (1.9) 6 (6.4) - 0.11†
Edge inversion 1 (1.0) 2 (2.1) - 0.49†
Excessive distortion 2 (1.9) 2 (2.1) - 0.66†
Overall sub-optimal cosmetic appearance 8 (7.8) 10 (10.4) - 0.34†
Suboptimal wound (total WES score of <6) 11 (10.5) 13 (13.5) - 0.288†
Optimal wound (total WES score of 6) 94 (89.5) 83 (86.5) - 0.288†
Wound complication at day 14 using WES [No. (%) of patients]
Erythema/swelling 1 (1.0) 6 (6.4) - -
Infection 1 (1.0) 1 (1.1) - -
Minor dehiscence 1 (1.0) 1 (1.1) - -
Infection (ASEPSIS: 0-30) [mean±SD] 0.09±0.4 0.61±1.9 - 0.011*
Mean (range) visual analogue scale score for pain
Baseline (before wound closure) 36.9 (32.0-41.8) 33.6 (29.3-38.0) 3.3 (3.5-9.5) -
Day 14 10.5 (7.3-13.8) 14.9 (12.0-17.9) 4.4 (0.1-8.8) -
Month 1 3.6 (1.7-5.4) 8.4 (5.8-11.0) 4.8 (1.7-8.0) -
Month 3 1.1 (0.3-2.4) 4.1 (2.5-5.7) 3.0 (0.9-5.1) -
Mean±SD nurse time used (minutes) 20.8±9.1 28.1±8.2 - <0.005*
Mean±SD wound closure time (minutes) 9±2.4 15±30.9 - <0.005*
Overall patient satisfaction score (0-100) 91.6 85.3 - <0.0005*
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Table 3. Cost to the Hospital Authority
* Nurse time hourly rate=(mean monthly salary x 12)/(52 x working hours per week)=(HK$23 584 x 12)/(52 x 44); doctor time hourly rate=(mean monthly salary 
x 12)/(52 x working hours per week)=(HK$58 345 x 12)/(52 x 44); and administrative clerk hourly rate=(mean monthly salary x 12)/(52 x working hours per 
week)=(HK$10 000x12)/(52 x 44)
Variable Unit cost 
(HK$)
Dermabond (n=105) Suture (n=96)
No. of 
patients 
receiving 
service
Mean 
duration 
of service 
received 
(minutes)
Mean cost
per person 
(HK$)
No. of 
patients 
receiving 
service
Mean 
duration 
of service 
received 
(minutes)
Mean 
cost per 
person (HK$)
Costs for wound closure
Costs for equipment, drugs, and materials
Normal saline 0.9% for wound dressing 5.2/L 105 - 1.04 96 - 1.04
Local analgesia for sutures (Lignocanie 
1%)
2.4/5 mL 4 - 0.13 96 - 2.40
5 ml syringe for infiltration 0.40 4 - 0.02 96 - 0.40
Sterile suture set 3.00 4 - 0.16 96 - 3.00
Simple dressing set 2.70 105 - 2.70 96 - 2.70
Gauze x2 packs 0.36 105 - 0.72 96 - 0.72
Sterile glove 1.70 105 - 1.70 96 - 1.70
Suture material (4’O /5’O) x2 packs 8.25 4 - 0.90 96 - 16.50
Dermabond 140.00 105 - 140.00 0 - 0
Mean±SD subtotal 147.37±5.06 28.46
Absolute difference (95%CI) 118.91 (117.86-119.93)
Costs for analgesia
Panadol 500 mg x5 days (20 tabs) 21.0 47 - 10.61 51 - 11.51
Dologesic x5 days (15 tabs) 18.7 9 - 1.81 21 - 4.22
Mean±SD subtotal 12.42±10.17 15.73±8.59
Absolute difference (95%CI) 3.31 (0.59-6.04)
Costs for human resources*
Costs for assessment by doctor 5.10 105 5 25.5 96 5 25.50
Costs for wound closure by nurse 
(procedure)
2.06 105 9 18.41 96 15 30.90
Cost for triage care and advice 2.06 105 12 24.72 96 12 24.72
Costs for reassessment by doctor 5.10 105 1 5.10 96 2 10.20
Mean±SD subtotal 61 ±10.77 78.6 ±12.07
Absolute difference (95%CI) 17.59 (14.75-21.37)
Mean±SD total costs for wound closure per 
person
233.52±18.41 135.51±15.54
Absolute difference (95%CI) 98.01 (92.59-102.46)
Costs for subsequent wound care 
Costs for equipment and materials in suture 
removal
Normal saline 0.9% for wound dressing 5.2/L 4 - 0.06 96 - 1.04
Simple dressing set 2.70 4 - 0.15 96 - 2.70
Sterile glove 1.70 4 - 0.09 96 - 1.70
Costs for equipment and materials in 
wound dressing
Normal saline 0.9% for wound dressing 5.2/litre 7 (25 visits) - 0.27 75 (194 visits) - 2.16
Simple dressing set 2.70 7 (25 visits) - 0.72 75 (194 visits) - 5.63
Sterile glove 1.70 7 (25 visits) - 0.45 75 (194 visits) - 3.54
Mean±SD subtotal 1.74±7.44 16.77±10.12
Absolute difference (95%CI) 15.03 (12.41-17.55)
Costs for human resources*
Costs for suture removal by nurse 2.06 4 8 0.89 93 8 16.48
Costs for wound dressing by nurse 2.06 7 (25 visits) 6 3.32 75 (194 visits) 6 25.65
Costs for subsequent assessment by 
doctor
5.10 3 5 0.82 3 5 0.82
Costs for subsequent assessment by 
out-patient doctor
5.10 2 5 0.55 3 5 0.82
Cost for administrative work by clerk 0.87 34 visits 3 0.85 293 visit 3 7.97
Mean±SD subtotal 6.43±22.95 51.74±24.90
Absolute difference (95%CI) 38.19 (31.26-45.12)
Mean±SD total costs for subsequent wound 
care per person
8.17±30.20 68.51±34.79
Absolute difference (95%CI) 60.34 (43.74-62.60)
Mean±SD overall cost to the Hospital 
Authority per person 
241.69±40.92 204.02±39.19
Absolute difference (95%CI) 37.67 (32.76-55.95)
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Dermabond. 
Cost-effectiveness: patient consideration 
The cost-effectiveness analysis did not include charges 
to patients. Normally each patient needed to pay HK$17 
for each dressing, HK$45 for wound reassessment, and 
HK$100 for each AED attendance. The Dermabond 
method appeared to be favoured by patients owing to its 
lower overall charges to them, shorter procedure duration, 
less frequent follow-up visit, and better patient satisfaction. 
If a societal viewpoint was taken, which included patient 
costs and indirect costs such as the value of time taken from 
work, Dermabond appeared to be more cost-effective and 
could be adopted more widely and safely in Hong Kong if 
its supply cost was lower . 
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Fig 2. Comparison of visual analogue cosmesis scale (VACS) 
in Dermabond and suture groups
Fig 3. Comparison of visual analogue scale (VAS) score for 
pain in Dermabond and suture groups
M
ea
ns
 o
f V
A
C
S
 (0
-1
00
 m
m
)
Time
Day 0 Day 14 Month 1 Month 3
95
90
85
80
75
70
65
60
0
Dermabond
Sutures
VA
S
 s
co
re
 fo
r p
ai
n 
(0
-1
0 
cm
)
Time
Before wound 
closure
Day 14 Month 1 Month 3
4
2
0
Dermabond
Sutures
